loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 203340 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Azurity Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NIMODIPINE (2)

    filter

    01 AZURITY (2)

    filter

    01 SOLUTION;ORAL (2)

    filter

    01 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

    02 6MG/ML (1)

    filter

    01 USA (2)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Nimodipine

      PDF Supplier PDF
      URL Supplier Web Content
      SOLUTION;ORAL
      3MG/ML **Federal Regis...
      NYMALIZE
      USA
      203340
      2013-05-10
      DISCN
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Nimodipine

        PDF Supplier PDF
        URL Supplier Web Content
        SOLUTION;ORAL
        6MG/ML
        NYMALIZE
        USA
        203340
        2020-04-08
        RX
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        Looking for CTD TGA MCC DOSSIER APPLICATION 203340

        Looking for CTD TGA MCC DOSSIER APPLICATION 203340 2

        19

        Azurity Pharma, based in U.S.A, is a pharmaceutical company.

        One of their notable products is NIMODIPINE, with a corresponding application number 203340 and regulatory information .

        proudly manufactured in the

        approval since 2013-05-10

        Azurity Pharma's NYMALIZE SOLUTION;ORAL, medication with 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NIMODIPINE.

        18

        Azurity Pharma, based in U.S.A, is a pharmaceutical company.

        One of their notable products is NIMODIPINE, with a corresponding application number 203340 and regulatory information .

        proudly manufactured in the

        approval since 2020-04-08

        Azurity Pharma's NYMALIZE SOLUTION;ORAL, medication with 6MG/ML of NIMODIPINE.

        Post Enquiry
        POST ENQUIRY